4.8 Article

Unveiling the Template-Dependent Inhibition on the Viral Transcription of SARS-CoV-2

Related references

Note: Only part of the references are listed.
Article Biochemistry & Molecular Biology

Efficient incorporation and template-dependent polymerase inhibition are major determinants for the broad-spectrum antiviral activity of remdesivir

Calvin J. Gordon et al.

Summary: The antiviral effects of Remdesivir (RDV) are strongly correlated with its efficient incorporation of RDV-TP. Inhibition in primer extension reactions is often inefficient at higher NTP concentrations, while template-dependent inhibition of UTP incorporation opposite the embedded RDV-MP is seen with all polymerases.

JOURNAL OF BIOLOGICAL CHEMISTRY (2022)

Article Biochemistry & Molecular Biology

Structural insight into the binding interactions of NTPs and nucleotide analogues to RNA dependent RNA polymerase of SARS-CoV-2

Shruti Koulgi et al.

Summary: The study investigates the structural variations of RdRP and its binding with nucleotide analogues, where certain residues were found to have significant interactions with the ligands, potentially aiding in the design of new inhibitors.

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2022)

Article Chemistry, Physical

2?- and 3?-Ribose Modifications of Nucleotide Analogues Establish the Structural Basis to Inhibit the Viral Replication of SARS-CoV-2

Yongfang Li et al.

Summary: This study evaluated the potential of nucleotide analogues with ribose modifications as obligate chain terminators for SARS-CoV-2 RdRp through molecular dynamics simulations and structural analysis. The results showed that 2'-modification affected structural stability, while 3'-hydrogen substitution immediately terminated the chain without compromising the stability. This provides a promising modification scheme for further optimization of inhibitors.

JOURNAL OF PHYSICAL CHEMISTRY LETTERS (2022)

Review Chemistry, Medicinal

RNA-dependent RNA polymerase (RdRp) inhibitors: The current landscape and repurposing for the COVID-19 pandemic

Lei Tian et al.

Summary: The RdRp enzyme, a therapeutic target for RNA virus infections, plays a crucial role in RNA synthesis. Promising RdRp inhibitors currently in studies offer potential for developing more effective anti-RNA virus drugs, which may be used for COVID-19 treatment in the current health emergency.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)

Article Multidisciplinary Sciences

Mechanism of SARS-CoV-2 polymerase stalling by remdesivir

Goran Kokic et al.

Summary: Remdesivir is the only FDA-approved drug for treating COVID-19 patients, working by inhibiting the RNA-dependent RNA polymerase (RdRp) of coronaviruses. It hinders RNA synthesis and impairs proofreading by the viral 3'-exonuclease, leading to a stalled replication process.

NATURE COMMUNICATIONS (2021)

Article Chemistry, Multidisciplinary

Modeling the Binding Mechanism of Remdesivir, Favilavir, and Ribavirin to SARS-CoV-2 RNA-Dependent RNA Polymerase

Fabian Bylehn et al.

Summary: This study examined the molecular interactions of Remdesivir, ribavirin, and favilavir, revealing that they all bind strongly at the active site but may act via slightly different mechanisms. Remdesivir showed similar binding interactions to the natural base adenine, suggesting a potential secondary mechanism where it destabilizes the protein complex and interactions with RNA strands.

ACS CENTRAL SCIENCE (2021)

Article Biology

Inhibition of SARS-CoV-2 polymerase by nucleotide analogs from a single-molecule perspective

Mona Seifert et al.

Summary: Remdesivir, the only FDA-approved drug for SARS-CoV-2, disrupts viral replication by stopping the polymerase. Through the use of magnetic tweezers, researchers have shown how remdesivir interferes with replication.

ELIFE (2021)

Article Chemistry, Multidisciplinary

Reviving chloroquine for anti-SARS-CoV-2 treatment with cucurbit[7] uril-based supramolecular formulation

Cheryl H. T. Kwong et al.

Summary: Research has shown that a supramolecular formulation of chloroquine by the macrocyclic host, cucurbit[7]uril, can decrease chloroquine's toxicity and enhance its antiviral activity against coronaviruses, working synergistically with cucurbit[7]uril. Cucurbit[7]uril alone also exhibits remarkable antiviral activity against SARS-CoV-2 and other coronaviruses, and significantly improves the antiviral activity of the chloroquine-cucurbit[7]uril formulation, suggesting great potential as a safe and effective antiviral agent.

CHINESE CHEMICAL LETTERS (2021)

Article Biochemistry & Molecular Biology

Remdesivir is a delayed translocation inhibitor of SARS-CoV-2 replication

Jack P. K. Bravo et al.

Summary: Remdesivir, a nucleoside analog approved by the US FDA for treating COVID-19, was found to delay chain termination by blocking RNA translocation on RNA-dependent RNA polymerase, providing insights for rational design of improved antiviral drugs.

MOLECULAR CELL (2021)

Review Chemistry, Multidisciplinary

The point-of-care-testing of nucleic acids by chip, cartridge and paper sensors

Yuyue Xu et al.

Summary: Point-of-care nucleic acid testing (POCNAT) plays a crucial role in infectious disease outbreaks, offering rapid, simple, and automated detection of nucleic acid. Leveraging advancements in technology, novel experimental carriers like chips, cartridges, and papers have been employed for automated nucleic acid detection, marking significant progress in the field.

CHINESE CHEMICAL LETTERS (2021)

Review Respiratory System

Repurposed pharmacological agents for the potential treatment of COVID-19: a literature review

Alina Kroker et al.

Summary: The search for pharmacological treatment of COVID-19 has led to controversial results, with chloroquine, hydroxychloroquine, and lopinavir/ritonavir showing no proven benefit. Remdesivir and dexamethasone have shown favorable results and are recommended for clinical use in treating COVID-19, while further research is needed for other pharmacological treatment strategies.

RESPIRATORY RESEARCH (2021)

Article Chemistry, Physical

Probing remdesivir nucleotide analogue insertion to SARS-CoV-2 RNA dependent RNA polymerase in viral replication

Moises Ernesto Romero et al.

Summary: Computational studies have shown that RDV-TP can stably bind to the SARS-CoV-2 RdRp active site and form base stacking, with a lower free energy barrier for insertion; while ATP binds to the active site in Watson-Crick base pairing and inserts with a lower barrier.

MOLECULAR SYSTEMS DESIGN & ENGINEERING (2021)

Article Chemistry, Physical

Incorporation efficiency and inhibition mechanism of 2′-substituted nucleotide analogs against SARS-CoV-2 RNA-dependent RNA polymerase

Congmin Yuan et al.

Summary: The ongoing pandemic caused by SARS-CoV-2 highlights the need for effective therapeutics. Inhibition of SARS-CoV-2 RdRp by nucleotide analogs offers a promising antiviral strategy. Research on 2'-modified nucleotides shows varying inhibitory effects on SARS-CoV-2 RdRp, which could potentially aid in the rational design of antiviral agents.

PHYSICAL CHEMISTRY CHEMICAL PHYSICS (2021)

Article Biochemistry & Molecular Biology

Dissecting nucleotide selectivity in viral RNA polymerases

Chunhong Long et al.

Summary: This article reviews the structural biology and computational clues of representative single-subunit viral polymerases related to the SARS-CoV-2 RdRp. It compares the nucleotide selectivity among different viruses' RdRps and explores the structural and biochemical characteristics of SARS-CoV-2 RdRp. Additionally, the article discusses computational findings on phage T7 RNA polymerase and human mitochondria RNAP, highlighting the importance of proofreading strategies in synthesizing large viral genomes.

COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2021)

Article Chemistry, Physical

1′-Ribose cyano substitution allows Remdesivir to effectively inhibit nucleotide addition and proofreading during SARS-CoV-2 viral RNA replication

Lu Zhang et al.

Summary: Remdesivir effectively inhibits SARS-CoV-2 viral RNA replication by interfering with nucleotide addition and proofreading mechanisms, reducing the likelihood of viral replication. The molecular dynamics simulations provide insights into the inhibitory mechanisms of Remdesivir, guiding potential rational designs for new COVID-19 treatments targeting viral replication.

PHYSICAL CHEMISTRY CHEMICAL PHYSICS (2021)

Article Medicine, General & Internal

A Novel Coronavirus from Patients with Pneumonia in China, 2019

Na Zhu et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Biochemistry & Molecular Biology

Structural Basis for RNA Replication by the SARS-CoV-2 Polymerase

Quan Wang et al.

Article Multidisciplinary Sciences

Structure of the RNA-dependent RNA polymerase from COVID-19 virus

Yan Gao et al.

SCIENCE (2020)

Article Virology

The potential chemical structure of anti-SARS-CoV-2 RNA-dependent RNA polymerase

Jrhau Lung et al.

JOURNAL OF MEDICAL VIROLOGY (2020)

Article Multidisciplinary Sciences

Structure of replicating SARS-CoV-2 polymerase

Hauke S. Hillen et al.

NATURE (2020)

Article Chemistry, Physical

Structural Basis of the Potential Binding Mechanism of Remdesivir to SARS-CoV-2 RNA-Dependent RNA Polymerase

Leili Zhang et al.

JOURNAL OF PHYSICAL CHEMISTRY B (2020)

Article Biochemical Research Methods

Nucleotide Analogues as Inhibitors of SARS-CoV-2 Polymerase, a Key Drug Target for COVID-19

Minchen Chien et al.

JOURNAL OF PROTEOME RESEARCH (2020)

Article Biochemistry & Molecular Biology

Template-dependent inhibition of coronavirus RNA-dependent RNA polymerase by remdesivir reveals a second mechanism of action

Egor P. Tchesnokov et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2020)

Article Multidisciplinary Sciences

Structure of the SARS-CoV nsp12 polymerase bound to nsp7 and nsp8 co-factors

Robert N. Kirchdoerfer et al.

NATURE COMMUNICATIONS (2019)

Review Chemistry, Multidisciplinary

Elucidation of the Dynamics of Transcription Elongation by RNA Polymerase II using Kinetic Network Models

Lu Zhang et al.

ACCOUNTS OF CHEMICAL RESEARCH (2016)

Article Multidisciplinary Sciences

Millisecond dynamics of RNA polymerase II translocation at atomic resolution

Daniel-Adriano Silva et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)

Article Chemistry, Physical

The Structural Role of Mg2+ Ions in a Class I RNA Polymerase Ribozyme: A Molecular Simulation Study

Jacopo Sgrignani et al.

JOURNAL OF PHYSICAL CHEMISTRY B (2012)

Article Biology

Stepwise mechanism for transcription fidelity

Yulia Yuzenkova et al.

BMC BIOLOGY (2010)

Article Biochemistry & Molecular Biology

Ribonucleoside Triphosphates as Substrate of Human Immunodeficiency Virus Type 1 Reverse Transcriptase in Human Macrophages

Edward M. Kennedy et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2010)

Article Multidisciplinary Sciences

Structural basis for active site closure by the poliovirus RNA-dependent RNA polymerase

Peng Gong et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)

Article Biochemistry & Molecular Biology

RNA polymerase fidelity and transcriptional proofreading

Jasmin F. Sydow et al.

CURRENT OPINION IN STRUCTURAL BIOLOGY (2009)

Article Biochemistry & Molecular Biology

Can Morphing Methods Predict Intermediate Structures?

Dahlia R. Weiss et al.

JOURNAL OF MOLECULAR BIOLOGY (2009)

Article Biochemistry & Molecular Biology

Hepatitis C virus RNA-dependent RNA polymerase (NS5B) as a mediator of the antiviral activity of ribavirin

D Maag et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2001)